Browsing Tag
Sofinnova Partners
6 posts
Neurent Medical secures €25m growth debt to expand NEUROMARK commercialization
Neurent Medical has secured a €25 million growth-debt facility from Claret Capital after completing a €62.5 million Series C, giving the chronic rhinitis device company additional commercial firepower without immediately returning to shareholders for another equity round.
Bionyra raises $165m to build an immunology company from licensed assets
Bionyra launches with $165 million and three licensed immunology drugs. Read how its portfolio-first model could reshape biotech company creation.
How NanoPhoria’s record €83.5m raise could transform heart failure treatment—and put Italian biotech on the global map
NanoPhoria Bioscience raises €83.5M to advance its novel heart-failure therapy and expand its nano delivery platform. Find out how it’s changing biotech today.
Bioptimus hits major funding milestone, unveils plans for transformative biology model
Bioptimus, a Paris-based leader in artificial intelligence innovation, has reached a remarkable funding milestone of $76 million, underscoring…
Gradient Denervation raises €14m for pulmonary hypertension treatment
Gradient Denervation Technologies has successfully closed a €14 million Series A financing round to support the clinical development…
French biotech company Amolyt Pharma Series C round fetches $138m
Amolyt Pharma, a France-based clinical-stage biotechnology company, has secured €130 million (around $138 million) from a Series C…